Potential classification of chemical immunologic response based on gene expression profiles

Area of Science:

• Immunology
• Toxicology
• Dermatology

Background:

• Occupational immune diseases pose a significant public health challenge, often linked to low molecular weight (LMW) chemical exposure.
• The precise immunological mechanisms underlying chemical allergen classification remain incompletely understood.
• Antimicrobials represent a diverse group of LMW agents with potential immunomodulatory effects.

Purpose of the Study:

• To investigate the distinct immunological responses induced by dermal exposure to various antimicrobial chemicals.
• To characterize the mRNA expression profiles of cytokines and cellular mediators following exposure to sensitizers, irritants, and adjuvants.
• To identify unique gene expression patterns associated with specific antimicrobial agents.

Main Methods:

• Mice were dermally exposed to representative antimicrobial chemicals: didecyldimethylammonium chloride (DDAC), ortho-phthalaldehyde (OPA), benzalkonium chloride (BAC), and triclosan (TCS).
• Real-time quantitative PCR (qPCR) was employed to evaluate mRNA expression of cytokines and cellular mediators in various tissues over a 7-day period.
• Analysis focused on danger signals (Tslp, S100a8), T H 2 cytokines (Il4, Il13), and cellular adhesion molecules (Ecad).

Main Results:

• All tested antimicrobials increased mRNA expression of danger signals Tslp (skin) and S100a8 (skin, blood, lung).
• The T H 2 cytokine Il4 exhibited time-dependent expression peaks varying with exposure duration.
• Unique expression profiles were observed for OPA (Il10 in lymph node; Il4, Il13 in lung) and TCS (Tlr4 in skin).
• Except for OPA, all chemicals reduced the expression of the cellular adhesion molecule Ecad.

Conclusions:

• Dermal exposure to diverse antimicrobial agents elicits unique gene expression profiles.
• Understanding the mechanisms of antimicrobial-induced immunomodulation is crucial for developing preventative and therapeutic strategies.
• These findings support the need for further research to advance chemical toxicity screening and treatment for immune diseases.